The majority leadership in Congress is considering establishing work requirements in Medicaid, but if work requirements were established in states that have expanded their programs, more than 5 million people could lose their coverage, according to a n…
A new report shows decelerating growth for Medicare Advantage plans.
Health insurer Humana and independent primary care network Aledade are expanding their partnership, extending services to rural health clinics and federally qualified health centers (FQHCs) with an eye toward achieving and sustaining value-based care.
Cyberattacks can affect any hospital but have a disproportionate effect on smaller hospitals.
Fitch Ratings recently took credit action on two nonprofit health systems, downgrading both after each experienced a crippling cyberattack.
While most cyber e…
Optum Rx has signaled a shift to a cost-based pharmacy reimbursement model that’s intended to have pharmacies pay more for brand-name drugs and less for generics.
The model will reduce variation in how pharmacies are paid.
Hospitals across the U.S. are seeing steady financial performance, driven by increased patient volumes, even as high expenses remain a persistent challenge, according to Kaufman Hall’s January 2025 National Hospital Flash Report.
The report, based on d…
An administrative law judge at the North Carolina Office of Administrative Hearings has reaffirmed the State Health Planning Agency’s approval of Mission Hospital’s Certificate of Need (CON) application for a new emergency room in West Asheville, accor…
The American Hospital Association and the nonprofit Health-ISAC (Information Sharing and Analysis Center) are warning of a potential terrorist threat against U.S. hospitals in the coming weeks.
A vulnerability in ChatGPT that was identified last year is being used by would-be cyberattackers to target security flaws in artificial intelligence systems, with the healthcare industry one of the top targets, according to a report from Veriti.
Weight loss drugs such as Wegovy and Zepbound are clinically effective but not cost effective at their current prices, according to a study published in JAMA Health Forum.
